<p>Pulse oximeters, blood pressure monitoring machines, nebulisers, digital thermometers and glucometers have become cheaper as the government capped trade margins on these critical medical devices.</p>.<p>The Chemicals and Fertilsers Minister had noted that the data collected from the manufacturers /marketers/importers pointed out that existing trade margins on the five medical devices ranged up to 709% from price to distributor to MRP level.</p>.<p>The maximum downward revision has been reported by an imported brand of pulse oximeter, showing reduction of Rs 2,95,375 per unit, it added.</p>.<p>The downward revision of MRP has been reported by imported and domestic brands across all the categories, the Chemicals and Fertilisers Ministry said.</p>.<p>Medical devices sold by around 620 brands have witnessed reduction in prices so far. These devices are used extensively in the treatment and prevention of Covid-19.</p>.<p>On July 13, the National Pharmaceuticals Pricing Authority (NPPA) had invoked extraordinary powers under the Paragraph 19 of DPCO, 2013, to put a cap on trade margin of five medical devices -- oximeter, glucometer, BP monitor, nebuliser and digital thermometer.</p>.<p>The margin was capped up to 70% on Price to Distributor (PTD) level.</p>.<p>“Pursuant there to, a total of 684 products/brands of these medical devices have been reported as on July 23, 2021 and 620 products/brands (91%) have reported downward revision of MRP,” the ministry said in a statement.</p>.<p>The revised MRP effective from July 20, 2021 on all the brands and specifications has been shared with the state drug controllers for strict monitoring and enforcement, the ministry said.</p>
<p>Pulse oximeters, blood pressure monitoring machines, nebulisers, digital thermometers and glucometers have become cheaper as the government capped trade margins on these critical medical devices.</p>.<p>The Chemicals and Fertilsers Minister had noted that the data collected from the manufacturers /marketers/importers pointed out that existing trade margins on the five medical devices ranged up to 709% from price to distributor to MRP level.</p>.<p>The maximum downward revision has been reported by an imported brand of pulse oximeter, showing reduction of Rs 2,95,375 per unit, it added.</p>.<p>The downward revision of MRP has been reported by imported and domestic brands across all the categories, the Chemicals and Fertilisers Ministry said.</p>.<p>Medical devices sold by around 620 brands have witnessed reduction in prices so far. These devices are used extensively in the treatment and prevention of Covid-19.</p>.<p>On July 13, the National Pharmaceuticals Pricing Authority (NPPA) had invoked extraordinary powers under the Paragraph 19 of DPCO, 2013, to put a cap on trade margin of five medical devices -- oximeter, glucometer, BP monitor, nebuliser and digital thermometer.</p>.<p>The margin was capped up to 70% on Price to Distributor (PTD) level.</p>.<p>“Pursuant there to, a total of 684 products/brands of these medical devices have been reported as on July 23, 2021 and 620 products/brands (91%) have reported downward revision of MRP,” the ministry said in a statement.</p>.<p>The revised MRP effective from July 20, 2021 on all the brands and specifications has been shared with the state drug controllers for strict monitoring and enforcement, the ministry said.</p>
